Dermata Therapeutics's total assets for Q4 2023 were $7.98M, an increase of 8.95% from the previous quarter. DRMA total liabilities were $1.62M for the fiscal quarter, a 77.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.